icd-10 code for elevated bilirubin in a newborn

What is the ICD 10 for elevated bilirubin?

Total bilirubin, elevated ICD-10-CM E80.7 is grouped within Diagnostic Related Group(s) (MS-DRG v 38.0): 441 Disorders of liver except malignancy, cirrhosis or alcoholic hepatitis with mcc

What is neonatal hyperbilirubinemia?

It is a sign of neonatal hyperbilirubinemia. Most cases are transient self-limiting (physiological neonatal jaundice) occurring in the first week of life, but some can be a sign of pathological disorders, particularly liver diseases. ICD-10-CM P59.9 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 795 Normal newborn

What is the ICD 10 code for neonatal jaundice?

Neonatal jaundice, unspecified. P59.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM P59.9 became effective on October 1, 2018. This is the American ICD-10-CM version of P59.9 - other international versions of ICD-10 P59.9 may differ.

What is the ICD 10 code for newborns?

2016 2017 2018 2019 Billable/Specific Code Code on Newborn Record. P59.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM P59.9 became effective on October 1, 2018.

What is ICD-10 code for hyperbilirubinemia in newborn?

P59. 9 - Neonatal jaundice, unspecified | ICD-10-CM.

What is the diagnosis code for neonatal jaundice?

ICD-10 code: P59. 9 Neonatal jaundice, unspecified.

Is hyperbilirubinemia and jaundice the same?

Hyperbilirubinemia is a condition in which there is a build up of bilirubin in the blood, causing yellow discoloration of the eyes and skin, called jaundice.

What is the diagnosis code for hyperbilirubinemia?

E80. 7 - Disorder of bilirubin metabolism, unspecified. ICD-10-CM.

What is unspecified neonatal jaundice?

Neonatal jaundice from other and unspecified causes Yellow discoloration of the skin; mucous membrane; and sclera in the newborn. It is a sign of neonatal hyperbilirubinemia.

What is the ICD 10 code for obstructive jaundice?

Obstructive jaundice (OJ) or blockage of the bile duct code K83. 1 (according to ICD 10), occurs in approximately 45-50% of cases of all varieties of jaundice, it can be both non-tumor and tumor genesis.

What does it mean if a baby's bilirubin is high?

A newborn's immature liver often can't remove bilirubin quickly enough, causing an excess of bilirubin. Jaundice due to these normal newborn conditions is called physiologic jaundice, and it typically appears on the second or third day of life.

What is high bilirubin in babies?

Bilirubin is a yellow substance that the body creates when it replaces old red blood cells. The liver helps break down the substance so it can be removed from the body in the stool. A high level of bilirubin makes a baby's skin and whites of the eyes look yellow. This is called jaundice.

What if direct bilirubin is high in newborns?

If the bilirubin remains very high, above 25 mg/dl, babies can be at risk for significant brain damage. This very rare condition is called kernicterus. Because of that risk, the doctor will start testing early for the bilirubin level and repeat the test often to identify the trend and start treatment rapidly.

What is the ICD-10 code for unconjugated hyperbilirubinemia?

6: Other disorders of bilirubin metabolism.

What is the ICD-10 code for elevated liver enzymes?

ICD-10-CM Code for Elevation of levels of liver transaminase levels R74. 01.

What causes indirect hyperbilirubinemia?

Hyperbilirubinemia in children is usually unconjugated and most often caused by problems with red blood cell stability and survival or by defects in the bilirubin-conjugating enzyme, UGT. In contrast, disorders that result in conjugated hyperbilirubinemia are usually caused by intrinsic liver dysfunction.

What does yellow skin mean in newborns?

Yellow discoloration of the skin; mucous membrane; and sclera in the newborn. It is a sign of neonatal hyperbilirubinemia . Most cases are transient self-limiting (physiological neonatal jaundice) occurring in the first week of life, but some can be a sign of pathological disorders, particularly liver diseases.

What is physiologic jaundice?

Neonatal jaundice. Newborn physiological jaundice. Physiologic jaundice, neonatal. Clinical Information. Jaundice that appears during the neonatal period. In the majority of cases, it appears in the first week of life and is classified as physiologic due to accelerated destruction of erythrocytes and liver immaturity.

Is P59.9 on the maternal record?

P59.9 should be used on the newborn record - not on the maternal record. kernicterus ( P57.-) Jaundice that appears during the neonatal period. In the majority of cases, it appears in the first week of life and is classified as physiologic due to accelerated destruction of erythrocytes and liver immaturity.

Symptoms and Tests

Common symptoms of jaundice are yellow skin and white of eyes, dark coloured body fluids (urine and stool). If jaundice along with severe abdominal pain, blood vomit, blood in stool, change in mental function, fever or tendency to bleed easily are cause of concern.

Types of Jaundice

There are mainly 3 types of jaundice – Prehepatic, hepatic, posthepatic.

ICD 10 Codes for Jaundice and Coding guidelines

ICD 10 Codes for jaundice are located in different chapters in ICD book. ICD 10 Code for Neonatal jaundice are found in chapter 16 – conditions originating in perinatal period, code range P00 – P96

What is the name of the drug used for neonatal jaundice?

Aetna considers the use of metalloporphyrins (e.g., stannsopor fin (tin mesoporphyrin), Stanate, WellSpring Pharmaceutical Corporation, Neptune, NJ) for the treatment of neonatal jaundice experimental and investigational because their safety and effectiveness for this indication has not been established.

Can probiotics help with jaundice?

Chen and co-workers (2017) stated that probiotics supplementation therapy could assist to improve the recovery of neonatal jaundice, through enhancing immunity mainly by regulating bacterial colonies. However, there is limited evidence regarding the effect of probiotics on bilirubin level in neonates. These researchers systematically evaluated the safety and efficacy of probiotics supplement therapy for pathological neonatal jaundice. Databases including PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wan Fang Database (Wan Fang), Chinese Biomedical Literature Database (CBM), VIP Database for Chinese Technical Periodicals (VIP) were searched and the deadline was December 2016; RCTs of probiotics supplementation for pathological neonatal jaundice in publications were extracted by 2 reviewers. The Cochrane tool was applied to assessing the risk of bias of the trials. The extracted information of RCTs should include efficacy rate, serum total bilirubin level, time of jaundice fading, duration of phototherapy, duration of hospitalization, adverse reactions. The main outcomes of the trials were analyzed by Review Manager 5.3 software. The RR or MD with a 95 % CI was used to measure the effect. A total of 13 RCTs involving 1,067 neonatal with jaundice were included in the meta-analysis. Probiotics supplementation treatment showed efficacy [RR: 1.19, 95 % CI: 1.12 to 1.26), p < 0.00001] in neonatal jaundice. It not only decreased the total serum bilirubin level after 3 days [MD: -18.05, 95 % CI: -25.51 to -10.58), p < 0.00001], 5 days [MD: -23.49, 95 % CI: -32.80 to -14.18), p < 0.00001], 7 days [MD: -33.01, 95 % CI: -37.31 to -28.70), p < 0.00001] treatment, but also decreased time of jaundice fading [MD: -1.91, 95 % CI: -2.06 to -1.75), p < 0.00001], as well as the duration of phototherapy [MD: -0.64, 95 % CI: -0.84 to -0.44), p < 0.00001] and hospitalization [MD: -2.68, 95 % CI: -3.18 to -2.17), p < 0.00001], when compared with the control group. Additionally, no serious adverse reaction was reported. The authors concluded that this meta-analysis showed that probiotics supplementation therapy was an effective and safe treatment for pathological neonatal jaundice. Moreover, they stated that as the quality of included studies and the limitations of samples, the long-term safety and efficacy still need to be confirmed by long-term and high-quality research.